Through the Strategy To Accelerate Research (CMTA-STAR), CMTA brings together scientists, industry leaders, and the CMT community to accelerate treatment development across all of CMT. With more than $30 million invested since 2008, CMTA-STAR supports research from genetic discovery to clinical trial readiness, and everything in between. Use the links below to explore our collaborative research model, active projects, partnerships, the preclinical toolbox, and more.
What Is
CMTA-STAR?
CMTA-STAR is the Charcot-Marie-Tooth Association’s global initiative to advance treatments for CMT. Since 2008, it has united patients, researchers, clinicians, and industry to drive progress.
Click to Learn More
CMTA-STAR
Portfolio
Through its Strategy To Accelerate Research program (CMTA-STAR), CMTA funds and supports research around the world.
Click to Learn More
CMTA-STAR
Advisory Board
The CMTA-STAR Advisory Board brings together world-leading experts to guide and accelerate every stage of CMT research, from early discovery to clinical trial delivery and everything in between.
Click to Learn More
CMTA-STAR Alliance Partners
Patients as Partners in Research is how CMTA connects individuals with CMT to the research that needs them and connects research to the people it’s meant to serve.
Click to Learn More
CMTA-STAR Development Pipeline
The CMTA-STAR Development Pipeline offers a visual snapshot of active and emerging therapies being developed through CMTA-STAR.
Click to Learn More
Donate to CMTA-STAR
Because of your support, research is accelerating, clinical trials are underway, and families living with CMT have more answers and more hope than ever before. But we’re not done yet. We need your help to keep the momentum going and bring real treatments to the CMT community.
Click to Learn More
